Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06976203
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Testing effectiveness (Phase 2)UnknownNCT01255046
What this trial is testing

Study of STA-1 as an Add-on Treatment to Donepezil

Who this might be right for
Alzheimer Disease
Sinphar Pharmaceutical Co., Ltd 136
Large-scale testing (Phase 3)Ended earlyNCT00937352
What this trial is testing

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 896
Large-scale testing (Phase 3)Not Yet RecruitingNCT06964230
What this trial is testing

A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects

Who this might be right for
Alzheimer's Disease
T3D Therapeutics, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT00663936
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
FUJIFILM Toyama Chemical Co., Ltd. 373
Not applicableStudy completedNCT02973971
What this trial is testing

ADDIA Chronobiological Study

Who this might be right for
Alzheimer Disease
Amoneta Diagnostics SAS 24
Testing effectiveness (Phase 2)Looking for participantsNCT06597942
What this trial is testing

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Who this might be right for
Alzheimer&Amp;Amp;#39;s DiseaseAlzheimer DiseaseDementia Alzheimer Type+4 more
University of California, Los Angeles 54
Early research (Phase 1)Study completedNCT01193608
What this trial is testing

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00099710
What this trial is testing

Curcumin in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
John Douglas French Foundation 33
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Not applicableStudy completedNCT05527288
What this trial is testing

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Sinotau Pharmaceutical Group 50
Large-scale testing (Phase 3)Study completedNCT01249196
What this trial is testing

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
SK Chemicals Co., Ltd. 256
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)UnknownNCT05194163
What this trial is testing

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Neurokine Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT02560753
What this trial is testing

Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
T3D Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00357357
What this trial is testing

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Hunter-Fleming Ltd 40
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Next Page